TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance

Garcia Mayea, Yoelsis; Mir Perez, Cristina; Carballo Perich, Laia; Castellví Vives, Josep; Temprana Salvador, Jordi; Lorente Guerrero, Juan; Benavente Norza, Sergio; Lleonart Pajarin, Matilde

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Garcia Mayea, Yoelsis
dc.contributor.author	Mir Perez, Cristina
dc.contributor.author	Carballo Perich, Laia
dc.contributor.author	Castellví Vives, Josep
dc.contributor.author	Temprana Salvador, Jordi
dc.contributor.author	Lorente Guerrero, Juan
dc.contributor.author	Benavente Norza, Sergio
dc.contributor.author	Lleonart Pajarin, Matilde
dc.date.accessioned	2021-09-01T10:02:59Z
dc.date.available	2021-09-01T10:02:59Z
dc.date.issued	2020-11-05
dc.identifier.citation	Garcia-Mayea Y, Mir C, Carballo L, Castellvi J, Temprana-Salvador J, Lorente J, et al. TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance. Cancers. 2020 Nov 5;12(11):3269.
dc.identifier.issn	2072-6694
dc.identifier.uri	https://hdl.handle.net/11351/6247
dc.description	Apoptosi; Cèl·lules mare del càncer; Resistència
dc.description.sponsorship	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII): PI15/01262 (M.E.LL.) PI19/00560 (J.M.G.-P.) and CP03/00101 (M.E.L.), CIBERONC (CB16/12/00390 to J.P.R.), Ayudas a Grupos PCTI Principado de Asturias (IDI2018/155 to J.P.R.), co-financed by the European Regional Fund (ERDF) and AECC (Spanish Association of Cancer Research) Founding Ref. GC16173720CARR (M.E.L.). Y.G.-M. and C.M. were granted by the VHIR and iP-FIS (ISCIII) fellowships respectively.
dc.language.iso	eng
dc.publisher	MDPI
dc.relation.ispartofseries	Cancers;12(11)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Cèl·lules canceroses
dc.subject	Resistència als medicaments
dc.subject	Tumors
dc.subject.mesh	Carcinoma, Squamous Cell
dc.subject.mesh	Drug Resistance, Neoplasm
dc.title	TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.3390/cancers12113269
dc.subject.decs	carcinoma de células escamosas
dc.subject.decs	resistencia a los antineoplásicos
dc.relation.publishversion	https://www.mdpi.com/2072-6694/12/11/3269
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Garcia-Mayea Y] Grup de Recerca Biomèdica amb Cèl·lules Mare de Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Genetic, Microbiology and Statistics Department, Faculty of Biology, University of Barcelona, Barcelona, Spain. [Mir C, Carballo L, Castellvi J, Temprana-Salvador J] Grup de Recerca Biomèdica amb Cèl·lules Mare de Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Lorente J] Servei d’Otorrinolaringologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Benavente S] Unitat de Radioteràpia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [LLeonart ME] Grup de Recerca Biomèdica amb Cèl·lules Mare de Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.identifier.pmid	33167355
dc.identifier.wos	000592782100001
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01262
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00560
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00390
dc.rights.accessrights	info:eu-repo/semantics/openAccess